<DOC>
	<DOCNO>NCT02364752</DOCNO>
	<brief_summary>The aim 2-part study ass B-type natriuretic peptide ( BNP ) well circulate image biomarkers myocardial function . Part 1 ass biomarker level healthy participant participant cardiac dysfunction . Part 2 ass BNP circulate biomarker level , performs image participant cardiac dysfunction continue Part 1 . The primary hypothesis compare healthy participant , biomarker level elevate participant mild/moderate severe cardiac dysfunction .</brief_summary>
	<brief_title>A Study Evaluating Biomarkers Participants With Heart Failure ( MK-0000-344 )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Sodium Potassium Chloride Symporter Inhibitors</mesh_term>
	<criteria>female reproductive potential must demonstrate nonpregnant state , agree use two acceptable method birth control postmenopausal surgically sterile female Body Mass Index ( BMI ) &gt; = 18 = &lt; 35 kg/m^2 , inclusive healthy participant general good health participant HF untreated , significant health issue comorbidities , e.g . uncontrolled hypertension willing undergo echocardiography , CMR , study assessment participant HF diagnosis cardiomyopathy , slight moderate limitation physical activity , comfortable rest participant HF stable medical therapy HF two week prior start Part 1 participant HF stable diuretic regimen &gt; = 40 mg/day furosemide &gt; = 10 mg/day torsemide least 2 week prior start Part 1 clinically significant , uncontrolled renal , endocrine ( except Type II Diabetes ) , neurological , hepatic , immunological inflammatory disease history cancer ( malignancy ) major surgery donated/lost approximately 500 mL blood within 4 week prior screen participate another investigational trial within 4 week prior screen except permitted medication , use prescription , nonprescription drug herbal remedy 2 week prior enrollment completion trial take medication affect BNP level within 30 day prior screen undergoes highintensity physical exercise 1 week prior pretrial visit completion trial implant embedded metal object body response magnetic field could cause injury suffers claustrophobia make unable undergo CMR scan consumes alcohol 7 day prior screen completion study consumes excessive amount caffeinated beverage use cannabis regularly , illicit drug , history drug ( include alcohol ) abuse within prior 12 month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>